19/01 Orthocell posts quarterly revenue of A$3.2 million RE
16/01 Orthocell Finalizes Agreement With Biotechnology Company MT
16/01 Orthocell finalises strategic investment in Marine Biomedica RE
06/01 Orthocell posts A$3.2 million in revenue for quarter ended 31 December RE
06/01 Orthocell Posts 45% Revenue Growth for December 2025 Quarter MT
18/12 Orthocell Sells 100 Units of Nerve Repair Product in US MT
17/12 Canaccord Genuity Starts Orthocell at Speculative Buy with AU$1.33 Price Target MT
15/12 Orthocell Submits Application to the British Standards Institution for Approval for Commercial Distribution of Nerve Repair Product, Shares Up 3% MT
15/12 Orthocell submits regulatory application for commercial distribution of Remplir RE
10/12 Orthocell Sells Nerve Repair Product in Hong Kong MT
20/11 Orthocell Limited Announces Adoption of Remplir by Australian Urologists CI
20/11 Orthocell To Set Up Commercialization Advisory Board for Nerve Repair Product, Shares Up 7% MT
06/11 Orthocell Reports Sixth Consecutive Quarter of Record Revenue in September Quarter MT
05/11 Orthocell Appoints Second Distributor in Canada for Nerve Repair Product MT
03/11 Orthocell Says First Nerve Repair Product Surgical Case in Hong Kong Completed, Shares Up 4% MT
29/25/29 ASX Midday Sector Update: Materials Stocks Up, Healthcare Continues to Struggle MT
29/25/29 Orthocell Appoints MontsMed as Exclusive Distributor for Remplir in Hong Kong MT
29/25/29 Orthocell Appoints MontsMed as Its Exclusive In-Country Distributor for Hong Kong CI
20/25/20 Orthocell secures rights to high-value bone regeneration tech RE
20/25/20 Orthocell Signs MoU with Biotechnology Company; Shares Up 3% MT
19/25/19 Marine Biomedical announced that it expects to receive AUD 1.05 million in funding from Orthocell Limited CI
17/25/17 Orthocell says a$30m placement sees co positioned for rapid growth RE
17/25/17 Orthocell to Raise AU$30 Million via Placement MT
15/25/15 Orthocell requests trading halt for proposed capital raising RE
10/25/10 Orthocell Ltd reports quarterly revenue of A$3.0 million RE
No results for this search
  1. Stock Market
  2. Equities
  3. OCC Stock
  4. News Orthocell Limited